FUFikriye Uras

Fikriye Uras

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fikriye Uras has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biyokimyada Temel ve Özel Konular

    by Ayşen Yarat, Tuğba Tunalı Akbay, Ebru Işık Alturfan, Nezaket Eren, Ahmet Özaydın, H. Arzu Ergen, Sevim Tunalı, Ahmet Ata Alturfan, Elif Özkök, Tuğba Akbay, et al.

    Biyokimya, canlı sistemde gerçekleşen kimyasal olayları, bu sistemde yer alan tüm moleküllerin yapısını, bileşimini ve fonksiyonunu inceleyen bir bilim dalıdır. Temel biyokimya, biyokimyasal mekanizmaların moleküler düzeyde anlaşılması için alt yapıyı oluştururken hastalıklar ve tedavilerin öğrenilmesini kolaylaştırmaktadır. Biyokimyasal olayların normal bir şekilde gerçekleşmesi sağlığımızın temelini oluşturmakta; bu sistemin bozulması ile hastalıklar ortaya çıkmakta, hastalıklar için uygun ilaçların geliştirilmesi, kullanılması ve hastalıkların tedavi süreci başlamaktadır.

  • Open Access

    Gas6 expression and Tyrosine kinase Axl Sky receptors: Their relation with tumor stage and grade in patients with bladder cancer

    by Murat Akgül, Özgür Baykan, Zeynep Çağman, Mustafa Özyürek, İlKer Tinay, Cem Akbal, Fikriye Uras, Levent Türkeri

    Objectives: It has been shown that the dysregulation of tyrosine kinase Axl receptor and its ligand growth arrest-specific gene (Gas6) are associated with poor prognosis in various types of tumors but there is not enough study about their importance in bladder cancer (BC). We evaluated the relation of Gas6 gene expression and tyrosine- kinase Axl and Sky (Tyro 3) receptors with tumor stage and grade in patients with BC. Material and Methods: The study group consists of 55 patients whose transurethral resection of bladder (TUR-B) has been performed due to BC and the control group consists of 12 patients with normal bladder mucosa. In tissues mRNAs of Gas6, Axl, and Sky receptors were examined by quantitative (Real-Time) PCR (qPCR). Protein expression was measured by immunohistochemistry. Plasma Gas6 protein levels were compared with control group by ELISA method. Results: Patients with BC were grouped as Ta low (n=17), Ta high (n=5), T1 low (n=9), T1 high (n=8) and T2 (n=16) according to their TUR-B pathologies. The qPCR analysis showed that the expression of Gas6 gene and Axl receptor is higher in the tumor-positive group and the immune-histochemical showed that the bladder samples of the tumor-positive group stained significantly positive. When the patients are grouped according to the TUR-B pathologies, a statistical significant difference was observed among groups in the qPCR analysis ratios of Gas6 gene and Axl receptor by (p < 0.05) but no significance was found for Sky receptor (p > 0.05). When Gas6 protein levels in plasma samples were compared by ELISA method, a statistical significance was determined among groups (p = 0.001). Conclusions: Our findings indicate that mRNAs of Gas6 and Axl receptor are closely related to tumor stage and grade in patients with BC. Further studies are needed for understanding the role of Gas6 and its receptors on the neoplastic transformation in terms of novel biomarkers and potential therapeutic targets.


  • Plasma growth arrest-specific 6 levels in term and preterm newborns

    by Emel Eksi Alp, Nuvit Altinkaya, Zeynep Cagman, Fikriye Uras

    Objective: Growth Arrest-Specific 6 (GAS6) is a vitamin K-dependent protein. Despite a similar structure to Protein S, it has no anticoagulant activity. An association between GAS6 and some diseases for adults has been reported. In the absence of prospective clinical studies of GAS6 in neonates, so far, the objective of this study is to obtain, for the first time, plasma GAS6 levels before and after vitamin K1 prophylaxis in full-term and pre-term newborns. Methods: 80 newborns (40 term and 40 preterm) were recruited for this study. Cord blood samples and peripheral blood samples 48 h after vitamin K1 injection were collected into EDTA-tubes. GAS6 levels were measured in platelet-poor plasma by ELISA. Results: Cord blood plasma GAS6 levels in preterm and term newborns were 9.07 ± 5.30 ng/mL and 9.75 ± 4.34 ng/mL, respectively. In response to vitamin K1 injection, GAS6 levels increased in preterm newborns (10.50 ± 5.28 ng/mL) (p < .05), but not in term newborns (9.12 ± 3.42 ng/mL, p > .05). Conclusion: This pilot study provided, to the best of our knowledge, the first report that GAS6 levels increased significantly after vitamin K1 prophylaxis in preterm newborns but not in term infants. This study may serve as a first step toward more extensive studies in neonates.


  • Endemik Tanacetum argenteum subsp. argenteum bitkisinin toprak üstü kısımlarından elde edilen ekstrelerin biyolojik aktiviteleri

    by Ali Şen, Özlem Bingöl Özakpınar, Seher Birteksöz Tan, Şükran Kültür, Fikriye Uras, Leyla Bitiş

    Bu çalışmanın amacı, Tanacetum argenteum subsp. argenteum bitkisinin toprak üstü kısımlarından elde edilen n-hekzan, kloroform, metanol ve sulu metanol ekstrelerinin antimikrobiyal ve antiproliferatif aktivitelerini araştırmaktır. Ekstrelerin antiproliferatif aktivitesi dört farklı insan kanser hücre hatlarına (A549: Akciğer adenokarsinoma, Hela; Serviks adenokarsinoma, HT-29: Kolon adenokarsinoma, MCF-7; Meme adenokarsinoma) karşı MTT yöntemiyle test edilmiştir. Ekstrelerin antimikrobiyal aktivitesi ise Staphylococcus aureus ATCC 29213, Staphylococcus epidermidis ATCC 12228, Escherichia coli ATCC 25922, Enterococcus faecalis ATCC 29212, Klebsiella pneumoniae ATCC 4352, Pseudomonas aeruginosa ATCC 27853, Proteus mirabilis ATCC 14153, ve Candida albicans ATCC 10231 suşlarına karşı mikro-broth dilüsyon yöntemiyle araştırılmıştır. Kloroform ekstresi 30 μg/ mL konsantrasyonda HT-29 and MCF-7 hücre hatlarının gelişimini sırasıyla % 89 ve % 73 oranında durdururken, n-hekzan ekstresi ise aynı konsantrasyonda bu hücre hatlarının gelişimini sırasıyla % 75 ve % 74 oranında inhibe etmiştir. Aynı zamanda kloroform ekstresi A-549 and HeLa hücre hatlarının gelişimi sırasıyla % 75 ve % 62 oranında durdurarak önemli bir antiproliferatif aktivite göstermiştir. Kloroform ekstresi, Staphylococcus aureus and S. epidermidis’e karşı 625 μg/ mL’lik MİK değerleriyle orta derecede antibakteriyel aktivite göstermiştir. Metanol ve sulu methanol ekstreleri ise 1250 μg/mL’lik MİK değerleriyle Staphylococcus epidermidis ve Candida albicans suşlarına karşı zayıf antimikrobiyal aktivite göstermiştir. Bu sonuçlar, n-hekzan ve kloroform ekstresinin bu çalışmada kullanılan insan kanser hücre dizilerine karşı önemli bir antikanser aktiviteye sahip olduklarını gösterdi.


  • Reference intervals for growth arrest-specific 6 protein in adults

    by Zeynep Cagman, Ozlem Bingol Ozakpinar, Zeynep Cirakli, Asuman Gedikbasi, Pinar Ay, David Colantonio, Ahmet Riza Uras, Khosrow Adeli, Fikriye Uras

    The objective of this study was to establish reference intervals for growth arrest-specific 6 (GAS6), a vitamin K-dependent protein, in human adult plasma according to the Guideline of Clinical and Laboratory Standards Institute (CLSI) C28-A3. Blood samples were collected from 308 healthy volunteers aged 18–72 (157 female, 151 male). A non-parametric approach was used to calculate the reference interval. The plasma GAS6 reference interval was determined, with 90% confidence interval: the lower limit (2.5 percentile) was 2.5 (1.9–3.1) μg/L and the upper limit (97.5 percentile) = 18.8 (18.0–22.3) μg/L. Harris-Boyd’s test did not suggest partitioning by age or gender: medians for males [7.8 (5.8–10.7) μg/L] and females [9.9 (7.1–13.5) μg/L]. Three age-subgroups were tested: 18–29 years (n = 168); 30–44 years (n = 73); 45–72 years (n = 67). The intra- and inter-assay variations were 12.6% (mean, 5.2 ± 0.7 μg/L) and 14.0% (mean, 9.2 ± 1.3 μg/L), respectively. The mean recovery was 104%. This study reports plasma GAS6 reference intervals established first according to the guideline of CLSI C28-A3.


  • Open Access

    Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets

    by Fikriye Uras, Burhanettin Küçük, Özlem Bingöl Özakpınar, Ahmet Muzaffer Demir

    Growth arrest-specific 6 (Gas6) is a newly discovered vitamin K-dependent protein, which is a ligand for TAM receptors [Tyro3 (Sky), Axl, and Mer] from the tyrosine kinase family. Gas6 knockout mice were resistant to venous and arterial thrombosis. There are contradictory reports on the presence of Gas6 and its receptors in mouse platelets. The objective of this study was to investigate whether Gas6 and its receptors were present in mouse platelets or not. Specific pathogen-free BALB/c male and female mice of 8-10 weeks old and 25-30 g in weight were anesthetized under light ether anesthesia and blood samples were taken from their hearts. RNAs were isolated from isolated platelets, and then mRNAs encoding Gas6 and TAM receptors were detected by reverse transcription-polymerase chain reaction (RT-PCR). Protein concentrations of Gas6 and TAM receptors in platelets were measured by ELISA, but not those of Mer, because of the absence of any commercial ELISA kit for mouse specimens. RT-PCR results indicated the presence of mRNAs encoding Gas6 and Mer in mouse platelets. However, although RT-PCR reactions were performed at various temperatures and cycles, we could not detect the presence of mRNAs encoding Axl and Tyro3 (Sky). Receptor protein levels of Axl and Tyro3 were below the detection limits of the ELISA method. We found the presence of mRNAs encoding Gas6 and the receptor Mer in mouse platelets, but not Axl and Tyro3. Gas6, Axl, and Tyro3 protein levels were below the detection limits of the ELISA. The presence of mRNA is not obvious evidence of protein expression in platelets that have no nucleus or DNA. Further studies are required to clarify the presence of Gas6/TAM receptors in platelets using real-time PCR and more sensitive immunological methods, and future studies on mechanisms will indicate whether the Gas6/TAM pathway is a strategy for treatment of disorders.


  • Open Access

    Differentiation of hematopoietic stem cells isolated from peripheral blood to megakaryocyte

    by Ozlem Bingol Ozakpinar, Anne Marie Maurer, Cafer Adiguzel, Ozlem Tugce Cilingir, Muzaffer Demir, Fikriye Uras

  • Open Access

    Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

    by Sude Eminzade, Fikriye Uras, Fikret V Izzettin

    The first line anti-tuberculosis drugs isoniazid (INH), rifampicin (RIF) and pyrazinamide (PZA) continues to be the effective drugs in the treatment of tuberculosis, however, the use of these drugs is associated with toxic reactions in tissues, particularly in the liver, leading to hepatitis. Silymarin, a standard plant extract with strong antioxidant activity obtained from S. marianum, is known to be an effective agent for liver protection and liver regeneration. The aim of this study was to investigate the protective actions of silymarin against hepatotoxicity caused by different combinations of anti-tuberculosis drugs.